Aelis Farma Wins €458,000 Grant for Obesity R&D Aelis Farma secured a €458,000 grant on Apr 7, 2026 to fund obesity research; the award is modest versus clinical-stage R&D budgets but offers targeted validation.

Aelis Farma Wins €458,000 Grant for Obesity R&D: Aelis Farma secured a €458,000 grant on Apr 7, 2026 to fund obesity research; the award is modest versus clinical-stage R&D budgets but offers… 👈 Read full analysis #AelisFarma #ObesityResearch #HealthcareInnovation #Pharmaceuticals #ClinicalTrials

Citius Pharmaceuticals Elects Board, Ratifies Auditor Citius Pharmaceuticals held its annual meeting on Apr 6, 2026; shareholders elected board members and ratified one auditor, per Investing.com (Apr 6, 2026).

Citius Pharmaceuticals Elects Board, Ratifies Auditor: Citius Pharmaceuticals held its annual meeting on Apr 6, 2026; shareholders elected board members and ratified one auditor, per Investing.com… 👈 Read full analysis #CitiusPharmaceuticals #Pharmaceuticals #Investing #Shareholders #BoardMeeting

Graphic labeled “BLACK INK: Cannabis has no confirmed fatal overdoses – the drugs killing people are legal,” showing a split image with a jar of cannabis on one side and an open prescription pill bottle spilling tablets on the other, with PotCultureMagazine.com and Pot Culture Magazine logo visible at the bottom.

BLACK INK:

Cannabis has no confirmed fatal overdoses

The drugs that kill people are legal

#PotCultureMagazine #BlackInk #Cannabis #Pharmaceuticals #CannabisCulture #LegalVsIllegal #420Community

As the Iran war disrupts supplies, will it affect access to medicines? | The-14 War-driven supply disruptions may threaten medicine access if prolonged, exposing fragile global chains despite safeguards that protect short term availability!

As the Iran war disrupts supplies, will it affect access to medicines?
#War #GlobalHealth #Medicine #SupplyChain #Crisis #Pharmaceuticals #Healthcare #WarImpact #MiddleEast #Geopolitics #DrugShortage #GlobalEconomy #Logistics #Pharma #Trade #Infrastructure
the-14.com/as-the-iran-...

Upsher-Smith Launches Generic CiproDex® Eye Drops Enhancing Product Range Upsher-Smith Laboratories has introduced a generic version of CiproDex® eye drops, marking a significant expansion in its product portfolio.

Upsher-Smith Launches Generic CiproDex® Eye Drops Enhancing Product Range #USA #pharmaceuticals #Upsher-Smith #Maple_Grove #CiproDex

Amgen Posts Positive Results for Subcutaneous Tepezza Amgen's Apr 6, 2026 topline shows positive late-stage results for subcutaneous Tepezza; company filings cite ~ $1.2bn Tepezza sales in 2023, accelerating potential market access change.

Amgen Posts Positive Results for Subcutaneous Tepezza: Amgen's Apr 6, 2026 topline shows positive late-stage results for subcutaneous Tepezza; company filings cite ~ $1.2bn Tepezza sales in 2023, accelerating potential… 👈 Read full analysis #Amgen #Tepezza #Pharmaceuticals #Biotech #ClinicalTrials

Today in Global Small Business: Use AI to Expand Your Imagination and Pursue a Meaningful Life ©iStock/VR_Studio What's affecting me, my clients, my colleagues and other global small business owners: We should teach young people to use...

The Global Small Business Blog: Today in Global Small Business: Use AI to Expand Your Imagination and Pursue a Meaningful Life: www.globalsmallbusinessblog.com/2026/04/toda... #globalsmallbusiness #globalsmallbusinessblog #ai #meaningfullife #tariffs #pharmaceuticals #ecommerce

Akari Therapeutics Partners with WuXi XDC on ADCs Akari Therapeutics' Apr 6, 2026 ADC tie-up with WuXi XDC could accelerate preclinical timelines as the ADC market is projected at ~13.8% CAGR to 2030 (Grand View Research, 2024).

Akari Therapeutics Partners with WuXi XDC on ADCs: Akari Therapeutics' Apr 6, 2026 ADC tie-up with WuXi XDC could accelerate preclinical timelines as the ADC market is projected at ~13.8% CAGR to 2030 (Grand View… 👈 Read full analysis #AkariTherapeutics #WuXiXDC #ADCs #Biotechnology #Pharmaceuticals

#Health #FDA #Pharmaceuticals #research #RFK #Jr. #STAT+ #wellness

Origin | Interest | Match

The latest tariff move isn’t just about healthcare—it’s rewriting global finance rules. From pricing pressures to shifting manufacturing hubs, the ripple effects are being felt across worldwide.

Explore analysis: go-infofinance.com/blog/trump-d...

#FinanceNews #Pharmaceuticals #GlobalEconomy

Neurocrine Nears $2.5bn Deal for Soleno Neurocrine is reportedly in talks to buy Soleno for >$2.5bn (FT Apr 6, 2026). Soleno sells the first commercial therapy for hyperphagia in Prader-Willi syndrome.

Neurocrine Nears $2.5bn Deal for Soleno: Neurocrine is reportedly in talks to buy Soleno for >$2.5bn (FT Apr 6, 2026). Soleno sells the first commercial therapy for hyperphagia in Prader-Willi syndrome. 👈 Read full analysis #Neurocrine #Soleno #Pharmaceuticals #Acquisition #Healthcare

Vericel Wins Up to $197M BARDA Contract Vericel secured a ten-year BARDA contract worth up to $197M on Apr 2, 2026, implying an average annual procurement value of ~$19.7M and improved revenue visibility.

Vericel Wins Up to $197M BARDA Contract: Vericel secured a ten-year BARDA contract worth up to $197M on Apr 2, 2026, implying an average annual procurement value of ~$19.7M and improved revenue visibility. 👈 Read full analysis #Vericel #BARDA #Pharmaceuticals #ContractWins #NexoBrid

EPA moves to designate microplastics and pharmaceuticals as contaminants in drinking water Proposal, a win for RFK Jr’s Maha movement, is a ‘first step’ toward tackling plastic pollution, advocates say

Sounds positive coming from the now limited EPA.

#EPA moves to designate #microplastics and #pharmaceuticals as contaminants in drinking water www.theguardian.com/environment/...

Pharmaceuticals face 100% tariffs in US US considers 100% tariffs on pharmaceuticals, impacting drug prices. Scope and exemptions unclear, s...

US considers 100% tariffs on pharmaceuticals, impacting drug prices. Scope and exemptions unclear, says Brookings Institution's Richard Frank. #Pharmaceuticals #News

EPA moves to designate microplastics and pharmaceuticals as contaminants in drinking water The Environmental Protection Agency proposed Thursday to include microplastics and pharmaceuticals on a list of contaminants in drinking water for the first time, a step that could lead to new

EPA moves to designate #microplastics and #pharmaceuticals as #contaminants in #drinkingwater not currently regulated under the Safe Drinking Water Act www.thecanadianpressnews.ca/world/epa-mo...

#joke #funny #humor #comedy #meme #memes #shitposting #COVID #WHO #CDC #PHARMACEUTICALS #CONSPIRACY #KAREN

Hellmann expands healthcare logistics with new Dubai South hub Located in Dubai South’s Logistics District, the site has access to Jebel Ali Port via a bonded corridor and cargo terminals at Al Maktoum Airport.

Located in Dubai South’s Logistics District, the site has access to Jebel Ali Port via a bonded corridor and cargo terminals at #AlMaktoumAirport.

#HellmannWorldwideLogistics #DubaiSouth #JebelAliPort #healthcare #healthcarelogistics #pharma #MiddleEast #pharmaceuticals #medicalproducts

JPMorgan Reduces Stake in Indivior While Other Funds Increase Investments JPMorgan Chase & Co. reduced its holdings in Indivior PLC by 47% during the third quarter, selling 183,798 shares and retaining 207,588 shares valued at approximately $5.01 million, representing about 0.15% of the company. Meanwhile, other institutional investors significantly increased their stakes. Oaktree Capital Management LP added over 246 million shares, raising its total holdings to roughly $6.22 billion, while Divisadero Street Capital Management LP increased its position to over 3.36 million shares valued at $81 million. Goldentree Asset Management LP and Jacobs Levy Equity Management Inc. acquired new stakes valued at $42.63 million and $33.5 million, respectively. Insider activity included purchases by directors Keith Humphreys and Daniel A. Ninivaggi, boosting their ownership by 15.42% and 4.80%, respectively. Analysts have varied perspectives: HC Wainwright increased its price target to $48 with a 'buy' rating, Zacks Research upgraded Indivior to 'strong-buy,' and Weiss Ratings lowered its rating to 'hold.' Indivior, a specialty pharmaceutical company focusing on addiction and mental health treatments, recently reported strong earnings, beating estimates with $0.82 EPS on $358 million revenue. Institutional investors own 60.33% of the stock, which trades at a market cap of $3.71 billion, with a twelve-month high of $38.00 and a low of $8.64.

JPMorgan Reduces Stake in Indivior While Other Funds Increase Investments

🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅

#investments #stocks #pharmaceuticals

View full AI summary:

PlaneAlert ICAO: A70E5B Tail: N554AV Flt: N554AV
Owner: AbbVie
Aircraft: Gulfstream G600
2026-04-03 10:46:50 CEST
GA6C Bizjet Biotech Pharmaceuticals
adsb planefence planealert by kx1t - wiki - adsbexchange - planefence

Pharmaceuticals face 100% tariffs in US US considers 100% tariffs on pharmaceuticals. Impact unclear due to potential exemptions and deals, ...

US considers 100% tariffs on pharmaceuticals. Impact unclear due to potential exemptions and deals, says Brookings Institution's Richard Frank. #pharmaceuticals #News

EPA Proposes New Drinking Water Rules Targeting Microplastics and Pharmaceuticals Across the U.S., Raising Concerns About What’s in Your Tap Water!
👉 Read the full story at NewsLink7.com

#Microplastics #DrinkingWater #EPA #WaterSafety #Pharmaceuticals #News #WorldNews #Noticias

US imposes 100 per cent tariff on patented drugs - Yes Punjab News US to impose up to 100% tariffs on patented drug imports, citing national security and supply chain risks under Trump policy.

US imposes 100 per cent tariff on patented drugs yespunjab.com?p=235771

#USTariffs #Pharmaceuticals #DonaldTrump #TradePolicy #USNews #BigPharma #DrugPrices #SupplyChain #APIs #GlobalTrade #IndiaPharma #ChinaPharma #HealthcarePolicy #EconomicNews

Trump signs order threatening up to 100% tariffs on pharmaceuticals Donald Trump unveiled sweeping new pharmaceutical tariffs on Thursday that could reach 100% unless drugmakers strike pricing deals with his administration. The move, tied to national security concerns...

#Evil #Trump #UnitedStates
#Pharmaceuticals #Tariffs

www.france24.com/en/americas/...

Bright Path Supports New Tariffs on Imported Pharmaceuticals amid National Security Concerns Bright Path welcomes President Trump's new tariffs on imported pharmaceuticals, advocating for American manufacturing and national security. The company is already operating domestically to produce essential medicines.

Bright Path Supports New Tariffs on Imported Pharmaceuticals amid National Security Concerns #United_States #Mesa #pharmaceuticals #Tariffs #Bright_Path

Original post on masto.ai

#MafiaState

I’m all for lower drug prices, but this will hurt #patients most.

#Trump sets 100% #drug #tariffs on companies that haven’t lowered prices
Makers of patented #pharmaceuticals can escape the import tax by agreeing to join Trump’s “most favored nation” program to reduce US drug […]

Innocan Pharma FY Results Show C$12.3m Net Loss Innocan reported FY2025 revenue of C$2.1m and a net loss of C$12.3m on Apr 2, 2026; cash C$6.8m implies roughly six months runway at estimated burn.

Innocan Pharma FY Results Show C$12.3m Net Loss: Innocan reported FY2025 revenue of C$2.1m and a net loss of C$12.3m on Apr 2, 2026; cash C$6.8m implies roughly six months runway at estimated burn. 👈 Read full analysis #InnocanPharma #Pharmaceuticals #FinancialResults #NetLoss #RevenueReport

PureTech Publishes Phase 2b IPF Results PureTech published Phase 2b IPF results on Apr 2, 2026 (Investing.com). IPF median survival ~3–5 years; two drugs have been approved since 2014, shaping commercial hurdles.

PureTech Publishes Phase 2b IPF Results: PureTech published Phase 2b IPF results on Apr 2, 2026 (Investing.com). IPF median survival ~3–5 years; two drugs have been approved since 2014, shaping commercial hurdles. 👈 Read full analysis #PureTech #IPF #Phase2b #ClinicalTrials #Pharmaceuticals

#Pharmaceuticals and personal care products and their sublethal and lethal effects in #aquatic organisms

cdnsciencepub.com/doi/full/10....

#personalcareproducts
#PPCPs
#prescriptiondrugs
#fragrances
#cosmetics
#contaminants
#sewage
#wastewater
#persistence
#bioaccumulation
#toxicity

Skye Bioscience Doses First Patient in Nimacimab Study Skye dosed the first patient in the nimacimab expansion study on Apr 2, 2026, marking an operational milestone; enrollment pace and biomarker data will determine impact.

Skye Bioscience Doses First Patient in Nimacimab Study: Skye dosed the first patient in the nimacimab expansion study on Apr 2, 2026, marking an operational milestone; enrollment pace and biomarker data… 👈 Read full analysis #SkyeBioscience #Nimacimab #ClinicalTrials #Biotechnology #Pharmaceuticals